The aim of this study was to determine the relative importance of Ca 2+ sensitization, ion channels, and intracellular Ca 2+ ([Ca 2+ ] i ) in the mixed constrictor/relaxation actions of superoxide anion on systemic and pulmonary arteries.
Introduction
Reactive oxygen species (ROS) are important second messenger molecules contributing to normal functioning of multiple cell-signalling pathways. 1 However, excessive or dysregulated ROS production or metabolism, termed oxidative stress, promotes enhanced contractility, vascular smooth muscle growth, and inflammation, associated with numerous cardiovascular diseases, including both systemic 2 and pulmonary 3, 4 hypertension.
Acutely, ROS have complex constricting and relaxing actions on the systemic vasculature, depending on the artery size, nature of preconstriction, amount and type of ROS being generated, and where it is being generated. 5 -8 The two principal ROS produced in living cells are superoxide anion and its dismutation product hydrogen peroxide, and they have distinct actions on the vasculature. Superoxide inhibits endothelium-dependent relaxation through scavenging of nitric oxide in both pulmonary and systemic arteries. 2, 3, 9 Systemically, hydrogen peroxide may mediate metabolic dilation in the coronary circulation 10, 11 and may be a candidate endothelium-derived hyperpolarizing factor (EDHF), a major component of endotheliumdependent relaxation in resistance sized arteries, 12 acting through opening of K + channels. 5, 10, 13 For reasons that are not fully understood mechanistically, but may make sense physiologically because of the need to match perfusion to ventilation, the pulmonary circulation responds differently to a number of stimuli, including ROS and hypoxia. In pulmonary arteries (PAs) hydrogen peroxide is more likely to be pro-contractile, 14 and EDHF is probably of lesser importance as a component of endothelium-dependent relaxation than it is systemically. 15, 16 PAs generally constrict in response to hypoxia, whereas systemic arteries generally relax. ROS are also implicated in this constriction, which, as a corollary of chronic obstructive pulmonary disease, can cause pulmonary hypertension (PH), although whether ROS production is increased or decreased during hypoxia in the pulmonary circulation remains controversial. 17, 18 In addition to the above, both superoxide and hydrogen peroxide contribute to endothelium-independent constriction through activation of multiple protein kinase pathways. 19 -21 Previously, we
showed that both superoxide and hydrogen peroxide directly constricted rat PA, acting predominantly through Rho-kinase 22 and protein kinase C (PKC), 14 respectively. Hydrogen peroxide also causes Ca 2+ release from ryanodine-sensitive stores. 14 
ROS-mediated
Rho-kinase activation is also implicated in chronic hypoxia-induced PH. 23 Superoxide does not directly constrict mesenteric or femoral arteries, but causes a concentration-dependent constriction/relaxation response in the presence of agonist pre-constriction. 22 In the present study, we set out to determine the nature of the differences in responses of rat pulmonary and mesenteric arteries (MAs) to superoxide, comparing the roles of Ca 2+ -sensitization, intracellular Ca 2+ and voltage-gated K + channels.
Materials and methods

Reagents and chemicals
Fura PE-3/AM was from Sigma (Poole, UK). L-012, (8-amino-5-chloro-7-phenylpyrido [3,4-d] 
Animals and tissues
This study conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Housing and handling of animals was also in accordance with UK Home Office regulations. Intra-PA (second to third order branches) and MAs (second to fourth order) were obtained from male Wistar rats (200 -250 g), killed by pentobarbital injection. Comparably sized coronary and renal arteries were similarly obtained.
Production and measurement of superoxide
Superoxide was generated within cells and tissues using LY83583. 24 We showed previously that this occurs in PASMC using three different measures of ROS production (MitoSOX, DHE, and L-012). 22 Block with superoxide dismutase (SOD), but not catalase confirmed superoxide as the principal species produced. 22 In the present study, we used L-012 
Western blot
For measurement of phosphorylation of myosin phosphatase-targeting subunit-1 (MYPT-1) and the 20 kDa myosin light chain (MLC 20 ), PA or MA were prepared, treated, and homogenized and protein extracted for western blot as described previously. 25 Membranes were blocked for 1 h with 5% skimmed milk, probed with primary antibody overnight at 48C (1:1000-1:5000 in 1% milk), followed by application of horseradish peroxidase-conjugated anti-IgG secondary antibody for 1 h at room temperature (1:5000 in 1% milk). Membranes were first probed with specific anti-phospho-antibodies, stripped for 1 h (Pierce stripping buffer), re-blocked, and re-probed with corresponding anti-'total' antibodies. Anti-phospho-MYPT-1 (thr-855) was from Upstate (UK), antiphospho-MLC 20 (ser-19), anti-MLC 20 , and anti-MYPT-1 were all from Cell Signalling (UK). HRP-conjugated anti-IgG secondary antibodies were from Sigma.
Electrophysiology
For electrophysiology, freshly isolated pulmonary artery smooth muscle cells (PASMCs) and mesenteric artery smooth muscle cells (MASMCs) were obtained from third to fourth order PA and MA, respectively, by enzymatic dispersion, as described previously. 27 Voltage-gated K + currents (K V ) were measured by whole-cell voltage-clamp. Cells were superfused with HEPES-buffered PSS containing 1 mmol/L paxilline and 10 mmol/L glibenclamide in order to inhibit Ca 2+ -activated and K ATP currents, respectively, and dialysed with HEPES-buffered intracellular solution containing 10 mmol/L EGTA, as described previously.
Statistical analysis
Data were analysed with SigmaStat (Systat Software, Inc., San Jose, CA, USA). Simple pair-wise comparisons were done by Student's t-test. Multiple comparisons of the effects of treatments against control, of inhibitors against treatments, and of PA against MA, were performed by one-way or two-way ANOVA, with pair-wise post-hoc tests, as appropriate. P , 0.05 was deemed significant. All data are expressed as mean + SEM.
Results
Preliminary experiments showed that, when arteries were preconstricted with U46619, 10 mmol/L LY83583 caused near-maximal constriction in PA, whereas in MA, it caused near-complete relaxation. Similarly, 10 mmol/L LY83583 also relaxed U46619-preconstricted renal (79.9 + 7.4% relaxation, n ¼ 2) and coronary arteries (44.3 + 13.6% relaxation, n ¼ 5), suggesting that MA is representative of the systemic circulation as a whole. 1 mmol/L LY83583 constricted both PA and MA (as shown previously 22 ). Similar responses were obtained when arteries were pre-constricted with phenylephrine (1 mmol/L) instead of U46619 (not shown). In subsequent experiments, we chose to compare responses between PA and MA in the presence of the NO synthase inhibitor nitro-L-arginine methyl ester (L-NAME, 1 mmol/L) in order to focus on the non-NO-related components of the responses to superoxide. The effects of L-NAME on these responses are presented in Supplementary material online, Figure S1 . All constrictor and relaxation responses to LY83583 in both PA and MA were unaffected by disruption of the endothelium (not shown).
LY83583 generates ROS and mediates both constriction and relaxation via ROS
As shown in Figure 1A , ROS production was significantly increased by both 1 and 10 mmol/L LY83583 in both PA and MA, with no significant differences in fold increases above control between the two artery types. ROS generation from 10 mmol/L LY83583 was inhibited by dicoumarol (10 mmol/L), a blocker of the NADPH:quinone oxidoreductase (diaphorase), in both MA and PA, confirming the intracellular origin of LY83583-derived ROS. 24 ROS production in MA and PA, and the similarity between the two, was not significantly altered by the presence of L-NAME (data not shown).
We confirmed that the actions of LY83583 on PA and MA were via ROS with the use of antioxidant enzymes catalase and SOD. In PA ( Figure 1B , left panels), 10 mmol/L LY83583 enhanced U46619/ L-NAME-induced constriction. This constriction was not significantly affected by catalase alone, but was almost abolished by the combination of catalase and SOD, and, as shown previously, 22 was significantly inhibited by SOD alone (not shown). In MA ( Figure 1B , right panels), 10 mmol/L LY83583 caused a near immediate sustained relaxation. In the presence of catalase, there was still a sustained relaxation but this was preceded by a transient constriction (peaking at 2.5 min), suggesting that only a part of the relaxation response was due to hydrogen peroxide. In the combined presence of SOD and catalase, however, there was no transient constriction, and the sustained relaxation induced by LY83583 was inhibited. In MA, SOD alone tended to enhance the rate of relaxation induced by 10 mmol/L LY83583 without revealing a transient constriction (not shown), consistent with a pro-relaxant effect of the excess hydrogen peroxide thus generated. 13 
Effects of LY83583 on Rho-kinase-dependent Ca 21 sensitization
Since we showed previously that superoxide enhances Rho-kinasemediated Ca 2+ sensitization in PA, 22 we next examined this pathway in MA and compared it with PA under similar conditions. Arteries were permeabilized with a-toxin and [Ca 2+ ] i clamped at pCa 6.9 (PA) or 6.4 (MA) to induce a small (10 -15% of max) preconstriction. In PA, 10 mmol/L LY83583 caused further constriction, whereas in MA it had no significant effect (Figure 2A ). Despite these differences, the Rho-kinase inhibitor Y27632 caused comparable overall inhibition of these constrictions in the two artery types (Figure 2A ). This comparison suggests that Rho-kinase is basally active in both artery types, but that LY83583 only influences activity of Rho-kinase in PA. However, when a-toxin permeabilized MA where additionally pre-constricted with U46619/L-NAME, 10 mmol/ L LY83583 caused a small but significant relaxation (see Supplementary material online, Figure S2 ). This relaxation was clearly smaller than that seen in non-permeabilized arteries and was abolished by prior incubation with Y27632 (see Supplementary material online, Figure S2 ).
To examine further the relationship between Rho-kinase-mediated phosphorylation and constriction in the two artery types, the effects of 1 and 10 mmol/L LY83583 on phosphorylation of MYPT-1 at thr-855 (specifically phosphorylated by Rho-kinase in rat vascular smooth muscle 25, 28 ) and MLC 20 at ser-19 were determined. This was performed in non-permeabilized MA, in order to establish how closely changes in MYPT-1 phosphorylation were mirrored by changes in MLC 20 phosphorylation under conditions where [Ca 2+ ] i was not clamped. As shown in Figure 2B , U46619/L-NAME enhanced phosphorylation of both MYPT-1 and MLC 20 in both PA (left panels) and MA (right panels). In PA, the further addition of 1 and 10 mmol/L LY83583 caused further enhancement of phosphorylation of both proteins. In MA, 1 mmol/L LY83583 had no significant effect on either phosphorylation target, whereas 10 mmol/L slightly (but not significantly) reduced MYPT-1 phosphorylation and greatly reduced MLC 20 phosphorylation (to below basal), in line with the large relaxations of U46619/L-NAME-pre-constricted MA seen in Figure 1 and see Supplementary material online, Figure S1 . Figure 5A ). In MA, however, paxilline delayed the relaxation response, which was Reactive oxygen species and vascular tone -induced tension (mN) in a-toxin permeabilized PA (pCa 6.9, left) and MA (pCa 6.4, right). 15 min applications of 10 mmol/L LY83583 caused further constriction in PA (representative of 24 + 5% increase, n ¼ 8), but had no effect in MA (representative of n ¼ 11). In both arteries these constrictions were relaxed by the Rho-kinase inhibitor Y27632 (10 mmol/L) (PA 81.6 + 3.3%, n ¼ 8 and MA 69.2 + 2.9%, n ¼ 11). (B) Example western blots and summary bar charts showing effects of 1 and 10 mmol/L LY83583 (1 LY or 10 LY) on MYPT-1 and MLC 20 phosphorylation in non-permeabilized PA (left) and MA (right), in the presence of 100 nmol/L U46619 and 1 mmol/L L-NAME (U46/LN). Ratio of phospho/total for each blot was calculated and effects of treatments expressed as a percentage change over control (untreated artery). Asterisk denotes significant enhancement vs. control (P , 0.05, PA n ¼ 10 -12, MA n ¼ 12). Dagger denotes significant increase (PA) or decrease (MA) in response to LY83583 compared with U46/LN alone (P , 0.05).
preceded by a transient constriction (similar to the effect of catalase), whereas 4-AP virtually abolished the relaxation ( Figure 5B) . Neither paxilline nor 4-AP had any effects on un-pre-constricted PA or MA (not shown). 1 mmol/L TEA had a similar effect on LY83583 responses to that of paxilline (not shown).
Effects of LY83583 on voltage-gated K 1 currents
In order to confirm that inhibition of 10 mmol/L LY83583-induced relaxation in MA by 4-AP was through inhibition of K V channels, we examined the effects of LY83583 on K V currents in freshly isolated MASMC by whole-cell voltage-clamp and compared them with PASMC. We examined the steady-state activation characteristic (V A ) of the current by applying a range of pre-conditioning potentials and then briefly stepping to an appropriate test potential and measuring the amplitude of the resultant tail current. As shown in Figure 6 , LY83583 caused a significant hyperpolarizing shift in V A in both MA and PA, with no significant difference in the size of the shift between the two cell-types (213.7 + 2.3 mV in MA and 210.8 + 1.7 mV in PA). 
Role of guanylyl cyclase inhibition in responses to LY83583
Since LY83583 may also influence vascular tone through inhibition of guanylyl cyclase, either directly or via ROS, 29 we examined responses to LY83583 in PA and MA in the presence of the guanylyl cyclase inhibitor ODQ (10 mmol/L). ODQ greatly enhanced the sensitivity of both artery types to U46619 (not shown), making it exceedingly difficult to match pre-constriction amplitudes to those obtained without ODQ, despite a reduction in U46619 concentration. Nevertheless, when pre-constricted with U46619/L-NAME/ODQ, both 1 and 10 mmol/L LY83583 still caused constriction in PA, and 10 mmol/L still caused relaxation in MA. However, 1 mmol/L was without effect in MA under these conditions (see Supplementary material online, Figure S4 ; compare with Figure 3 ).
Discussion
Our data show that in the presence of the prostanoid agonist U46619, superoxide (as generated by LY83583 24 ) constricts PA and causes either constriction or relaxation in MA, dependent on concentration. These fundamental differences occur both in the absence or presence of L-NAME, and are largely unaffected by ODQ. This suggests therefore, notwithstanding the importance of NO scavenging and guanylyl cyclase activity to endothelium-dependent relaxation, 2,3,9 that there are additional pathways through which ROS can influence vascular tone. MAs are likely to be representative of the systemic circulation as a whole since we also observed superoxide-induced relaxation in agonist pre-constricted coronary and renal arteries. Ca 2+ sensitization is the process through which an increased contractile force can be achieved without a concomitant increase in [Ca 2+ ] i and is thought to be present to varying degrees in all smooth muscles. 30 One way in which this occurs is through the MYPT-1 which, when phosphorylated on thr-855, primarily by Rhokinase, causes inhibition of myosin phosphatase, thus enhancing MLC 20 phosphorylation. 28, 30 In LY83583-stimulated PA, we observe a close correlation between MYPT-1 phosphorylation, MLC 20 phosphorylation and Y27632-sensitive constriction, suggestive of Rho-kinase-dependent Ca 2+ sensitization. In MA, we observe an apparent dissociation between MYPT-1 phosphorylation and MLC 20 phosphorylation (and hence constriction) during responses to superoxide; there was no significant effect of LY83583 on MYPT-1 phosphorylation despite a profound drop in MLC 20 phosphorylation and an associated relaxation. Similarly, the rather small relaxation induced by LY83583 in a-toxin permeabilized MA, apparently mediated through inhibition of Rho-kinase (and therefore indicative of a small degree of superoxidemediated Ca 2+ -de-sensitization), was not large enough to account for the near complete relaxation observed in non-permeabilized MA. These observed differences between MA and PA are curious when considering that, as far as is known, Rho-kinase is of similar importance to normal and hypertensive systemic blood pressure 31, 32 as it is to the pulmonary circulation. 33, 34 Although the importance of Rho-kinase in the mesenteric circulation reportedly diminishes with the size of the artery, 31 Ca 2+ -induced constrictions in a-toxin permeabilized PA and MA were similarly inhibited by the blocker of Rho-kinase, Y27632. These results suggest that either the sensitivity of the Rho-kinase pathway to ROS is less in MA than in PA, perhaps through differences in upstream signalling (e.g. src-family kinases arization, as shown previously with hydrogen peroxide, which hyperpolarizes mesenteric and coronary arteries predominantly through actions on K V channels, 5, 10 although BK Ca channels may also be affected. 35 Our observation that LY83583-induced relaxation was abolished by 4-AP or the combination of SOD and catalase, but only partially blocked by paxilline, TEA, or catalase alone, suggests that both superoxide and hydrogen peroxide contribute to the hyperpolarization, but that the principle K + channel type acted upon was K V , with at best a minor contribution from BK Ca . The lack of effect of ODQ on LY83583-induced relaxation in MA rules out the possibility that this relaxation is via ROS-mediated guanylyl cyclase activation and subsequent PKG-mediation K + channel opening.
In light of the fact that LY83583 was unable to relax PA, it was somewhat surprising that it caused a similar shift in the steady-state activation of the K V current in PASMC as it did in MASMC. However, the inability of 4-AP to prevent LY83583 from causing constriction in PA also refutes the supposition that ROS differentially modulate K V channel activity in PA (inhibition) and MA (activation). Recently, a direct comparison of K V channel characteristics in the two cell-types suggested that channels of this family are more numerous in PASMC, are more likely to be open in the negative range of membrane potentials, and are therefore more likely to contribute to resting membrane potential in PASMC than in MASMC. 27 18, 38 This is also relevant to a rat model of chronic hypoxia-induced PH, where a direct link has been made between enhanced superoxide production, Rho-kinase activation and enhanced PA contractility. 23 In MA pre-constricted with U46619, 1 mmol/L LY83583 did not elevate MYPT-1 phosphorylation or [Ca 2+ ] i but it nevertheless caused constriction. This constriction was also abolished by prior inhibition of guanylyl cyclase. These results suggest that, at this concentration, LY83583 is constricting MA independently of direct Rho-kinase activation. Futhermore, when pre-constricted with K + instead of U46619, the resultant Ca 2+ -independent LY83583-induced constrictions were much less sensitive to Y27632 in MA than in PA, but were blocked by a PKC inhibitor. This all suggests an alternative form of ROS-sensitive Ca 2+ -sensitization that has a stronger influence over tone in MA than in PA. While this differential involvement of PKC is interesting, particularly since it too is implicated in ROSmediated constriction, 14, 19 further analysis of the role of PKC in this constriction is beyond the scope of this study. Furthermore, why similar constrictions did not also occur in a-toxin permeabilized MA and how guanylyl cyclase/protein kinase G may be involved without interaction with Rho-kinase, remain undetermined. In summary, we observed effects of superoxide on both procontractile and pro-relaxant pathways in both MA and PA. Rho-kinase Ca 2+ -sensitization and Ca 2+ -influx pathways were only significantly activated in PA. An alternative pro-contractile pathway responsive to the lower concentration of LY83583, possibly involving PKC, was more prominent in MA. However, the K v current was enhanced in both PA and MA. These pathways combine to give a net response to the higher concentration of LY83583 of relaxation in MA and constriction in PA. This suggests a fundamental difference in the way basic signalling pathways interact and which ultimately have a greater influence over MLC 20 phosphorylation and tone. A better understanding of these differences may help with the development of antihypertensive therapies designed to specifically target the pulmonary or systemic vasculature.
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Supplementary material is available at Cardiovascular Research online.
